For citations:
The use of cabergoline for treatment of syndrome of ovarian hyperstimulation. Obesity and metabolism. 2012;9(4):48-50. (In Russ.) https://doi.org/10.14341/2071-8713-5130
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
